Can you take tadalafil (phosphodiesterase type 5 inhibitor) after a myocardial infarction (heart attack)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Take Tadalafil After a Heart Attack?

Tadalafil can be used after a myocardial infarction, but only after a minimum waiting period of 90 days and with careful cardiovascular assessment, provided the patient is not taking nitrates and does not have other high-risk cardiac conditions. 1

Critical Absolute Contraindications

The most important safety consideration is the absolute contraindication between tadalafil and nitrate therapy:

  • Patients must wait at least 48 hours after taking tadalafil before any nitrate can be administered due to the risk of profound hypotension, myocardial infarction, and death 2, 3, 4
  • This interaction occurs because tadalafil inhibits phosphodiesterase-5, which degrades cyclic guanosine monophosphate (cGMP), and when combined with nitrates causes markedly exaggerated and prolonged vasodilation 3, 4
  • The FDA label explicitly states that in patients requiring emergency nitrate therapy after tadalafil use, at least 48 hours must have elapsed since the last tadalafil dose 1

Timing After Myocardial Infarction

The FDA label specifically excludes patients with myocardial infarction within the last 90 days from tadalafil use 1:

  • Tadalafil is not recommended until at least 3 months have passed since the acute event 1
  • This waiting period allows for cardiac stabilization and assessment of residual ventricular function 1

Additional High-Risk Cardiac Exclusions

Even after 90 days, tadalafil remains contraindicated in patients with: 1

  • Unstable angina or angina occurring during sexual intercourse 1
  • New York Heart Association Class 2 or greater heart failure within the last 6 months 1
  • Uncontrolled arrhythmias 1
  • Hypotension (blood pressure <90/50 mm Hg) or uncontrolled hypertension 1
  • Stroke within the last 6 months 1

Cardiovascular Assessment Required

Before prescribing tadalafil to post-MI patients, physicians must: 1

  • Evaluate whether the patient's cardiovascular status makes sexual activity inadvisable, as there is inherent cardiac risk with sexual activity 1
  • Consider that tadalafil has mild systemic vasodilatory properties causing transient blood pressure decreases (mean maximal decrease of 1.6/0.8 mm Hg in healthy subjects) 1
  • Assess for left ventricular outflow obstruction (e.g., aortic stenosis), as these patients are particularly sensitive to vasodilators 1

Safety Data in Coronary Artery Disease

The available evidence suggests reasonable safety when used appropriately: 5, 6

  • A retrospective analysis of 12,487 men with erectile dysfunction (5% with coronary artery disease at baseline) showed the incidence rate of serious cardiovascular events was 0.40/100 patient-years with tadalafil versus 0.43/100 patient-years with placebo 5
  • The myocardial infarction rate in tadalafil-treated patients (0.43 per 100 patient-years) was actually lower than placebo (0.6 per 100 patient-years) and comparable to the age-standardized male population 6
  • Studies in patients with stable coronary artery disease showed tadalafil had no adverse effects on myocardial blood flow and may even augment flow during increased cardiac workload 7

Critical Clinical Pitfalls to Avoid

The most dangerous scenario is a post-MI patient on chronic nitrate therapy who takes tadalafil: 3, 4

  • Patients taking long-acting nitrates (such as isosorbide mononitrate) should never use tadalafil 4
  • If erectile dysfunction treatment is desired, consider transitioning from nitrate therapy to alternative antianginal agents (beta-blockers, calcium channel blockers, or ranolazine) if clinically appropriate 4
  • The American College of Cardiology emphasizes this is a Class III recommendation (harm), meaning the intervention should not be performed 3

Patient Counseling Essential Points

Patients must be instructed to: 1

  • Stop sexual activity immediately and seek emergency care if they experience chest pain, dizziness, or nausea during sex 1
  • Understand that if they develop anginal chest pain requiring nitroglycerin after taking tadalafil, they must inform emergency personnel that at least 48 hours must elapse before nitrate administration 1
  • Recognize that sexual activity itself places extra strain on the heart, particularly if the heart is already weakened from a previous heart attack 1

Post-MI Medication Considerations

The European Society of Cardiology guidelines emphasize that post-MI patients should be on: 2

  • Beta-blockers indefinitely (reduce mortality and reinfarction by 20-25%) 2
  • ACE inhibitors for those with reduced ejection fraction (<40%) or heart failure 2
  • These medications do not contraindicate tadalafil use but must be considered when evaluating overall cardiovascular status 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrates and Tadalafil Contraindication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tadalafil and Nitrate Contraindications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular effects of tadalafil.

The American journal of cardiology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.